Intimation regarding Closure of Trading window

Dr. Reddy's Laboratories Ltd. announced that its Board of Directors will convene on July 22, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. In accordance with SEBI insider trading regulations, the trading window for the company's securities will be closed from June 24, 2026, until July 24, 2026. This closure is standard practice ahead of financial result announcements to prevent insider trading.